Elite Pharmaceuticals, Inc.
USD0.37
-0.03 (-7.34%)
CEO
Nasrat Hakim
IPO Date
2000-02-24
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
OTC
Country
US
Open
$0.42
Prev. Close
$0.40
Day Low
$0.37
Day High
$0.42
52W Low
$0.33
52W High
$0.78
Market Cap
$0.39B
Volume
1.04M
| 7.7 |
| 31 Mar 2023 | FY | 48.6% | 12.9% | 15.2% | 10.8% | 0.13 | 2.75 | 6.7 |
| 31 Mar 2022 | FY | 45.9% | 27.6% | 35.3% | 25.3% | 0.11 | 2.82 | 4.0 |
| 31 Mar 2021 | FY | 46.8% | 20.0% | 31.5% | 19.4% | 0.15 | 2.10 | 11.1 |
| 31 Mar 2020 | FY | 44.3% | -12.5% | -21.0% | -9.0% | 0.38 | 1.19 | -26.0 |
| 31 Mar 2019 | FY | 37.9% | -122.6% | -81.4% | -38.0% | 0.35 | 1.28 | -8.8 |
| 31 Mar 2018 | FY | 52.9% | -49.2% | -19.9% | -11.9% | 0.22 | 2.68 | -21.7 |
| 31 Mar 2017 | FY | 38.8% | 39.5% | 14.9% | 11.1% | 0.10 | 5.50 | 33.0 |
| 31 Mar 2016 | FY | 64.1% | -5.5% | -6.1% | -2.1% | 0.33 | 3.59 | -305.9 |
| 12.6 |
| 30 Jun 2025 | Q1 | 67.7% | -14.6% | -12.3% | -5.3% | 0.14 | 7.23 | -33.4 |
| 31 Mar 2025 | Q4 | 54.1% | 53.1% | 31.8% | 17.6% | 0.20 | 4.88 | 6.8 |
| 31 Dec 2024 | Q3 | 42.6% | -75.8% | -29.9% | -12.0% | 0.31 | 3.27 | -13.3 |
| 30 Sept 2024 | Q2 | 43.4% | -58.5% | -23.3% | -12.5% | 0.24 | 3.52 | -9.4 |
| 30 Jun 2024 | Q1 | 45.1% | 3.3% | 1.1% | 0.7% | 0.20 | 3.08 | 86.7 |
| 31 Mar 2024 | Q4 | 43.1% | 18.5% | 5.8% | 4.0% | 0.20 | 3.07 | 11.7 |
| 31 Dec 2023 | Q3 | 43.1% | 4.5% | 1.5% | 0.9% | 0.17 | 1.94 | 50.3 |
| 30 Sept 2023 | Q2 | 45.5% | 105.5% | 33.1% | 21.1% | 0.17 | 1.82 | 1.6 |